Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $112.38 Average Price Target from Analysts

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year […]

Related Keywords

Greg Zante ,Marianna Mancini ,Maxim Group ,Therapeutics Inc ,Lifesteps Financial Inc ,Massmutual Trust Co ,Therapeutics Company Profile ,Global Retirement Partners ,Lindbrook Capital ,Nasdaq ,Jefferies Financial Group ,Viking Therapeutics ,Get Free Report ,Truist Financial ,Steps Financial ,Wealth Management ,Retirement Partners ,Get Free ,Viking Therapeutics Daily ,